Market research
6CQ.F Cresco Labs Inc
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 187M
- P/E ratio
- Not available
- Analyst target
- 14.41
- Dividend yield
- Not available
- Beta
- 1.81
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA22587M1068
- Market cap
- 187M
- P/E ratio
- Not available
- Analyst target
- 14.41
- Dividend yield
- Not available
- Beta
- 1.81
About
About Cresco Labs Inc
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
Research context
Cresco Labs Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 6CQ.F discussion.
5 years, 7 months ago
Cresco Labs Inc is currently in a long term downtrend where the price is trading 2.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.8.
Cresco Labs Inc's total revenue rose by 312.8% to $171M since the same quarter in the previous year.
Its net income has dropped by 72.1% to $-48M since the same quarter in the previous year.
Finally, its free cash flow grew by 113.2% to $6M since the same quarter in the previous year.
Based on the above factors, Cresco Labs Inc gets an overall score of 3/5.